Takumi Group Eastern Japan manufacturing hub and institutional scale facility
Tokyo Stock Exchange Prime: 4887

Takumi Group Holdings (Tokyo: 4887)

Financial performance, management strategy, and shareholder disclosures on the Tokyo Stock Exchange Prime Market.

1929
Founded
Over 90 years of pharmaceutical excellence
~3,060
Employees
Dedicated professionals across Japan
~700
Products
Generic pharmaceutical formulations
6
Factories
State-of-the-art domestic manufacturing plants
¥41.2B
Capital
Strong financial foundation
Tokyo Prime 4887
Stock
Listed on Tokyo Stock Exchange Prime Market

Shareholder & Financial Information

Exchange
Tokyo Stock Exchange
Prime Market (4887)
Paid-in Capital
¥41.2 Billion
Consolidated basis
Group Workforce
~3,060 Employees
Nationwide operations
Fiscal Year End
March 31
Annual reporting
Corporate Headquarters in Osaka
Osaka HeadquartersExecutive Management & Strategic Governance

Transparent executive governance ensuring sustainable shareholder value creation, proactive investor dialogues, and statutory compliance on the Tokyo Prime Market.

Capital Manufacturing Assets & Strategic Plant Complex
Capital Asset BaseHigh-Throughput Production Facilities

Continuous capital reinvestment in automation, isolator technology, and robotic packaging lines delivers consistent operating margins and market leadership in Japanese generic medicines.